@FierceMedDev: Thermo nabs Chinese approval of $13.6B Life Tech merger. More | Follow @FierceMedDev
@MarkHFierce: Even N.Y. Sen. Chuck Schumer spilled the beans about Carlyle Group's bid for J&J's Ortho Clinical diagnostics arm. Story | Follow @MarkHFierce
@MichaelGFierce: Cynapsus' sublingual strip for severe Parkinson's reduces side effects in a study. More from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Integra finalizes $235M deal for Covidien's surgical products line. News | Follow @EmilyWFierce
@GalenMoore: Bio-Path Holdings is raising $10M for its cancer drug delivery tech. Release | Follow @GalenMoore
> Insulet is expanding its sales force to accommodate growing pediatric insulin pump sales. Story
> California's Avantis Medical Systems raised nearly $1.8 million in new financing toward development of catheter-based endoscopic devices, initially for gastrointestinal tract cancers. Item
> Invision Heart in Nashville is building a smart, portable 12-lead EKG device that would upload patient data to the cloud so doctors can access it quickly. Story
> Derma Sciences ($DSCI), a major developer of medical devices and drugs focused on wound care, said it expects 2013 revenue to be up 7.7% compared to 2012. Item
> Castle Biosciences is promoting some encouraging early data for a predictive test it is developing for esophageal cancer. Item
Biotech News
@FierceBiotech: Merck clears an FDA panel with its clot-fighting vorapaxar. Story | Follow @FierceBiotech
@JohnCFierce: ICYMI: Roche 's dealmakers at pRED will continue their global shopping spree in 2014. More | Follow @JohnCFierce
@DamianFierce: Sarepta still climbing on renewed hopes for eteplirsen. Article | Follow @DamianFierce
@EmilyMFierce: Per the FDA's new stance on antibacterials, here's a list of household products containing triclosan. | Follow @EmilyMFierce
> Amarin endures another FDA delay as Vascepa languishes. More
> J&J shipping out diagnostics biz for $4.2B. Report
> Gentium shareholders cry foul on $1B Jazz deal. News
Pharma News
@FiercePharma: FDA: The social media guidance puzzle will be complete by July. More | Follow @FiercePharma
@TracyStaton: Hungary joins the club of EU countries approving Novartis' generic version of GSK's blockbuster Advair. News | Follow @TracyStaton
@EricPFierce: FDA investigator assigned to Europol to fight fakes being hawked online by drug rings. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI: Allergan rides high on patent backing for key drugs Lumigan and Restasis. Article | Follow @CarlyHFierce
> Actavis is pulling out of China; CEO says it's 'not worth the aggravation.' News
> FDA: The social media guidance puzzle will be complete by July. Story
> Impatient Bidvest prods Adcock for a deal as tussle with rival bidder escalates. Report
> J&J takes Carlyle's $4B offer for its Ortho Diagnostics unit. Item
Pharma Manufacturing News
> Merck recalls all lots of Liptruzet shipped since its May debut. Story
> Former Fresenius employee says he was fired for raising red flags. Article
> Premier supports new FDA compounder oversight plan. Report
> FDA assigns an agent to Europol in its fight against fakes. More
> Sources: Ranbaxy asks the FDA to let it make generic Diovan in U.S. News
> Actavis selling China assets as it exits that country. Item
Vaccines News
> CDC, FDA studies link Merck and GSK rotavirus vaccines to bowel blockages. Story
> BIO and Sanofi are pushing the FDA to tweak its drug shortage rule for vaccines. Story
> A Dendreon consultant has raised $8M for a cancer vaccine startup. Story
> Buzz: Merck and Novartis trying to iron out details of their business unit swap. Story
> AC Immune begins first trial of a tau-targeting Alzheimer's vaccine. Story
> Astellas and Takeda continue to advance vaccine strategies. Item